Human VEGF ELISA Kit
Cat# MBS824530-96
Size : 96Tests
Brand : MyBiosource
VEGF (VEGFA) ELISA Kit for Human
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS824530Background: Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF), a potent cytokine expressed by most malignant tumors, has critical roles in vasculogenesis and both physiological and pathological angiogenesis. VEGF produced by tumor… More details
Product Overview
Online Datasheet in PDFProduct Name
VEGF (VEGFA), ELISA Kit
Full Product Name
Human VEGF ELISA Kit
Product Gene Name
VEGFA elisa kit
Product Synonym Names
VEGF; Vascular endothelial growth factor A; VEGF-A; Vascular permeability factor; VPF
Species Reactivity
Human
Samples
Culture Supernatants, Serum, Plasma, Tissue Homogenates
Sensitivity
< 7 pg/ml
Specificity
The Human VEGF ELISA Kit allows for the detection and quantification of endogenous levels of natural and/or recombinant Human VEGF proteins within the range of 31.3 pg/ml - 2000 pg/ml.
Preparation and Storage
Shipped and store at 4 degree C for 6 months, store at -20 degree C for one year. Avoid freeze/thaw cycles.
Applications Tested/Suitable for VEGFA elisa kit
Sandwich ELISA (SE)
Other Notes
Small volumes of VEGFA elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for VEGFA purchase
MBS824530 is a ready-to-use microwell, strip-or-full plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the VEGF (VEGFA) ELISA Kit target analytes in biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing VEGFA. The ELISA analytical biochemical technique of the MBS824530 kit is based on VEGFA antibody-VEGFA antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect VEGFA antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, VEGFA. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).
Additional Details
NCBI/Uniprot data below describe general gene information for VEGFA. It may not necessarily be applicable to this product.
NCBI Official Full Name
vascular endothelial growth factor A isoform a
NCBI Official Synonym Full Names
vascular endothelial growth factor A
NCBI Official Symbol
VEGFA
NCBI Official Synonym Symbols
VPF; VEGF; MVCD1
UniProt Protein Name
Vascular endothelial growth factor A
UniProt Synonym Protein Names
Vascular permeability factor; VPF
Protein Family
VEGF coregulated chemokine
UniProt Gene Name
VEGFA
UniProt Synonym Gene Names
VEGF; VEGF-A; VPF
UniProt Entry Name
VEGFA_HUMAN
NCBI Protein Information
vascular endothelial growth factor A; vascular permeability factor
NCBI Summary for VEGFA
This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for VEGFA
Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth.
Show more Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Pathways associated with VEGFA elisa kit
| Products by Pathway | Pathway Diagram |
|---|---|
| Angiogenesis Pathway antibodies | Angiogenesis Pathway Diagram |
| Axon Guidance Pathway antibodies | Axon Guidance Pathway Diagram |
| Bladder Cancer Pathway antibodies | Bladder Cancer Pathway Diagram |
| Bladder Cancer Pathway antibodies | Bladder Cancer Pathway Diagram |
| Cellular Response To Hypoxia Pathway antibodies | Cellular Response To Hypoxia Pathway Diagram |
| Cellular Responses To Stress Pathway antibodies | Cellular Responses To Stress Pathway Diagram |
| Cytokine-cytokine Receptor Interaction Pathway antibodies | Cytokine-cytokine Receptor Interaction Pathway Diagram |
| Cytokine-cytokine Receptor Interaction Pathway antibodies | Cytokine-cytokine Receptor Interaction Pathway Diagram |
| Developmental Biology Pathway antibodies | Developmental Biology Pathway Diagram |
| EPH-Ephrin Signaling Pathway antibodies | EPH-Ephrin Signaling Pathway Diagram |
Diseases associated with VEGFA elisa kit
| Disease Name | Pubmed Publications |
|---|---|
| Neovascularization, Pathologic Antibodies | >1810 publications with VEGFA and Neovascularization, Pathologic |
| Retinal Diseases Antibodies | >1288 publications with VEGFA and Retinal Diseases |
| Macular Degeneration Antibodies | >868 publications with VEGFA and Macular Degeneration |
| Neoplasm Metastasis Antibodies | >466 publications with VEGFA and Neoplasm Metastasis |
| Choroidal Neovascularization Antibodies | >443 publications with VEGFA and Choroidal Neovascularization |
| Inflammation Antibodies | >429 publications with VEGFA and Inflammation |
| Diabetic Retinopathy Antibodies | >411 publications with VEGFA and Diabetic Retinopathy |
| Lung Diseases Antibodies | >378 publications with VEGFA and Lung Diseases |
| Macular Edema Antibodies | >304 publications with VEGFA and Macular Edema |
| Heart Diseases Antibodies | >259 publications with VEGFA and Heart Diseases |
Organs/Tissues associated with VEGFA elisa kit
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Vascular Antibodies | >7331 publications with VEGFA and Vascular |
| Blood Antibodies | >2809 publications with VEGFA and Blood |
| Eye Antibodies | >1265 publications with VEGFA and Eye |
| Lung Antibodies | >494 publications with VEGFA and Lung |
| Bone Antibodies | >488 publications with VEGFA and Bone |
| Muscle Antibodies | >430 publications with VEGFA and Muscle |
| Embryonic Tissue Antibodies | >390 publications with VEGFA and Embryonic Tissue |
| Heart Antibodies | >348 publications with VEGFA and Heart |
| Liver Antibodies | >331 publications with VEGFA and Liver |
| Kidney Antibodies | >313 publications with VEGFA and Kidney |
You might also be interested by the following products:
Cat#
Description
Cond.
Price Bef. VAT


